The Alzheimer's Association provides resources and support for individuals with Alzheimer's and their caregivers, covering topics such as diagnosis, treatments, legal and financial planning, caregiving, safety, and research. They also offer educational programs, virtual events, and an online community for support, as well as resources specific to different communities. The organization promotes brain health and offers research, clinical trials, and funding opportunities for international dementia research, as well as opportunities for advocacy and philanthropy. They partner with various corporations and sponsors to support their mission. Recently, they released a statement on the topline data of the Phase 3 trial of Lecanemab, a potential treatment for early Alzheimer's disease.